Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Michael J. Reardon

October 27, 2025

Presentation TCT 2025

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

Presenter: David Daniels

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Tsuyoshi Kaneko

October 27, 2025

Presentation TCT 2025

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Presenter: Paul Sorajja

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Stefan Blankenberg

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Bernard Prendergast

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

New England Journal of Medicine RCT: DanGer Shock: Operationalizing the Data

Presenter: Babar Basir

October 28, 2024

Presentation TCT 2024

Principal PI Perspectives on the New England Journal of Medicine RCT: DanGer Shock

Presenter: Jacob Moeller

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Advertisement

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Commentary

Percutaneous Transseptal Transcatheter Mitral Valve Replacement using a Dedicated Balloon Expandable Valve: 1 Year Outcomes from the ENCIRCLE Trial using the SAPIEN M3

Commentary

Tendyne Transcatheter Mitral Valve System in Patients with Severe Mitral Annular Calcification: One-year Outcomes from the SUMMIT Severe MAC Cohort

Commentary

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Commentary

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

What’s Going to Be Hot at TCT 2025

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

New England Journal of Medicine RCT: DanGer Shock: Operationalizing the Data

Principal PI Perspectives on the New England Journal of Medicine RCT: DanGer Shock

The EARLY TAVR Trial Editorial Commentary

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content